Prenatal treatment of congenital adrenal hyperplasia

Trends in Endocrinology and Metabolism

Volumn 9, Issue 7, 1998, Pages 284-289

  Forest, Maguelone G ^a   Morel, Yves ^a   David, Michel ^b  

^a HÔPITAL DEBROUSSE   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

CLINICAL TRIAL; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; ENZYME DEFICIENCY; FEMALE; FETUS; FETUS GROWTH; GENDER IDENTITY; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VIRILIZATION;

EID: 0032171295     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00067-8     Document Type: Article

References (35)

1. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res. 7:1973;509-519.
2. David M, Forest MG Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr. 105:1984;799-803.
3. Dörr HG, Sippell WG Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels. J Clin Endocrinol Metab. 76:1993;117-120.
4. Edwards CRW, Benediktsson R, Lindsay RS, Seckl JR 11 beta-hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects. Steroids. 61:1996;263-269.
5. Forest MG Prenatal diagnosis, treatment, and outcome in infants with congenital adrenal hyperplasia. Curr Opin Endocrinol Diab. 4:1997;209-217.
6. Forest MG, Dörr HG Prenatal treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: European experience in 223 pregnancies at risk [abst]. Pediatr Res. 33:1993;S3.
7. Forest MG, Bétuel H, David M Traitement anténatal de l'hyperplasie congénitale des surrénales par déficit en 21-hydroxylase: étude multicentrique. Ann Endocrinol (Paris). 48:1987;31-34.
8. Forest MG, Bétuel H, David M Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update 88 of the French multicentric study. Endocr Res. 15:1989;277-301.
9. Forest MG, David M, Morel Y Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol. 45:1993;75-82.
10. Forest MG, Morel Y, David M: 1992. Prenatal treatment of congenital hyperplasia (CAH) due to 21-hydroxylase deficiency: pubertal development in the first CAH female patient treated prenatally [abst 15.04.038, p512]. 9th International Congress of Endocrinology, Nice, August 30-September 5.
11. Forest MG, Morel Y, David M: 1996a. Prenatal treatment of congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. In Hibi I, Tanaka T, eds. Sexual Differentiation and Maturation. Rome, Chrissengraf, pp 77-89.
12. Forest MG, Morel Y, David M, 1996b. Traitement anténatal de l'hyperplasie congénitale des surrénales par déficit en stéroòde 21-hydroxylase. In Pons G, Cabrol D, Tourniaire M, eds. Les Traitements Médicamenteux du Fœetus. France, Springer-Verlag, pp 145-164.
13. Lajic S, Bui TH, Holst M, Ritzén M, Wedell A Prenatal diagnosis and treatment of adrenogenital syndrome prevents virilization of female fetuses. Läkartidningen. 94:1997;4781-4786.
14. Levine LS, Pang SY Prenatal diagnosis and treatment of congenital adrenal hyperplasia. J Pediatr Endocrinol. 7:1994;193-200.
15. Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab. 80:1995;2014-2020.
16. Meyer-Bahlburg HFL, Gruen RS, New MIet al. Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav. 30:1996;319-332.
17. Migeon CJ Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 70:1990;836-837.
18. Miller WL Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 78:1994;241-246.
19. Morel Y, Miller WL Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet. 20:1991;1-68.
20. Morel Y, Murena M, Nicolino M, Forest MG: 1992. Molecular genetics of the congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In Saez JM, Brownie AC, Capponi A, Chambaz EM, eds. Cellular and Molecular Biology of the Adrenal Cortex. Paris, Colloque INSERM, John Libbey Eurotext Ltd, pp 123-136.
21. Novy ML, Walsh SW Dexamethasone and estriol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. Am J Obstet Gynecol. 145:1983;920-931.
22. Pang S, Wallace MA, Hofman Let al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 81:1988;866-874.
23. Pang S, Clark AT, Freeman LCet al. Maternal side effects of prenatal dexamethasone therapy for fetal congenital hyperplasia. J Clin Endocrinol Metab. 75:1992;249-253.
24. Pepe GJ, Albrecht ED Regulation of the fetal primate adrenal cortex. Endocr Rev. 11:1990;151-176.
25. Plante E, Boliek C, Binkiewicz A, Erly WK Elevated androgen, brain development and language/learning disabilities in children with congenital adrenal hyperplasia. Dev Med Child Neurol. 38:1996;423-437.
26. Prader A, Gurtner HP Das Syndrom des Pseudohermaphrotismus masculinus bei kongenitaler Nebennierenindenhyperplasie ohne Androgenüberproduktion (adrenaler Pseudohermaphroditismus masculinus). Helv Pødiatr Acta. 10:1955;397-411.
27. Seckl JR, Miller WL How safe is long-term prenatal glucocorticoid treatment? J Am Med Assoc. 277:1997;1077-1079.
28. Speiser PW, Dupont J, Zhu Det al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest. 90:1992;584-595.
29. Trautman PD, Meyer-Bahlburg HF, Postelnek Jet al. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology. 20:1995;439-449.
30. Uno H, Lohmiller L, Thieme Cet al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev Brain Res. 53:1980;157-167.
31. Wedell AA, Thilen A, Ritzen EM, Stengler B, Luthman H Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 78:1994;1145-1152.
32. Whincup PH, Cook D, Papacosta O, Walker M Birth weight and blood pressure: cross sectional and longitudinal relations in childhood. Br Med. J 311:1995;773-776.
33. Wilson RC, Mercado AB, Cheng KC, New MI Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab. 80:1995;2322-2329.
34. Young MC, Cook N, Read GF, Hughes IA The pharmacokinetics of low-dose dexamethasone in congenital adrenal hyperplasia. Eur J Clin Pharmacol. 37:1989;75-77.
35. Zucker KJ, Bradley SJ, Oliver Get al. Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav. 30:1996;300-318.